DNase-mediated eDNA removal enhances D-LL-31 activity against biofilms of bacteria isolated from chronic rhinosinusitis patients.
Bactericidal activity
D-LL-31
D-enantiomer peptide
DNase I
chronic rhinosinusitis
eDNA
Journal
Biofouling
ISSN: 1029-2454
Titre abrégé: Biofouling
Pays: England
ID NLM: 9200331
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
pubmed:
11
12
2020
medline:
2
3
2021
entrez:
10
12
2020
Statut:
ppublish
Résumé
Chronic rhinosinusitis (CRS) is a chronic infection of the nasal cavity and paranasal sinuses associated with the presence of a microbial biofilm. Extracellular DNA (eDNA) is an important component of the biofilm matrix. Antimicrobial peptides (AMPs) are natural peptides with the ability to kill microorganisms. D-LL-31 is a synthetic variant of the AMP cathelicidin with increased resistance to proteolytic breakdown. In this study it is shown for 3 clinical CRS isolates that treatment of 24 h biofilms with DNase I enhanced the antimicrobial activity of D-LL-31. Conversely, co-incubation of D-LL-31 at the IC
Identifiants
pubmed: 33297738
doi: 10.1080/08927014.2020.1857741
doi:
Substances chimiques
Anti-Bacterial Agents
0
Deoxyribonucleases
EC 3.1.-
Deoxyribonuclease I
EC 3.1.21.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM